• 

  August 29, 2025

  Immune Checkpoint Inhibitor Side Effects & Toxicity More Common Than Reported

  Charles H. Weaver, MD

• 

  August 28, 2025

  Treatment of Stage II and III Bladder Cancer

  Charles H. Weaver, MD

• 

  August 3, 2025

  Treatment of Stage IV-Metastatic Cervical Cancer

  Charles H. Weaver, MD

• 

  January 7, 2025

  FDA Approves Subcutaneous Immunotherapy

  Charles H. Weaver, MD

• 

  April 11, 2024

  Checkpoint Inhibitor – Chemotherapy for Treatment of Small Cell Lung Cancer

  Charles H. Weaver, MD

• 

  March 14, 2024

  Checkpoint Inhibitor Immunotherapy for Treatment of Advanced Cervical Cancer

  Charles H. Weaver, MD

• 

  October 27, 2023

  Perioperative and Neoadjuvant Immunotherapy in Early Stage Lung Cancer

  Charles H. Weaver, MD

• 

  October 16, 2023

  Treatment of Stage II Melanoma

  Charles H. Weaver, MD

• 

  April 13, 2021

  Treatment of Stage I – III Non-Small Cell Lung Cancer

  Charles H. Weaver, MD

• 

  April 4, 2021

  Checkpoint Inhibitors Improve Treatment of Esophageal Cancer

  Charles H. Weaver, MD

• 

  March 28, 2021

  Relatlimab Anti-LAG-3 Antibody

  Charles H. Weaver, MD

• 

  March 6, 2021

  Top Medications Used to Treat Kidney (Renal Cell Cancer)

  Charles H. Weaver, MD